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Abstract
Background: It is extremely rare to see cerebrospinal fluid dissemination of intraventricular meningioma, particularly
with the development of acute, progressive brainstem/cerebellar dysfunction with an absence of mass formation in
the corresponding anatomical sites.
Case presentation: An 81-year-old man was admitted because of double vision, right facial nerve palsy and truncal
ataxia. Brain magnetic resonance imaging showed normal findings except for a tumor mass in the left lateral ventricle,
which had been noted over 6 months previously. The patient developed hiccups, hyperventilation, and drowsiness,
which worsened progressively, and did not respond to corticosteroid or intraventricular immunoglobulin therapy.
Cerebrospinal fluid study revealed a mild elevation of protein, and cytology was negative. The patient died and an
autopsy was performed. Postmortem investigation disclosed a malignant transformation of benign fibroid meningioma
with cerebrospinal fluid dissemination of the malignant cells, diversely involving the surface of brainstem, cerebellum,
and spinal cords, secondarily resulting in extensive ischemia in the brain parenchyma by vessel occlusion.
Conclusion: If a patient with an intraventricular tumor develops acute, progressive neurological symptoms, the
possibility that it is be caused by cerebrospinal fluid dissemination of tumor cells, after malignant transformation,
should be considered.
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Background
Intraventricular meningioma is a rare neoplasm, repre-
senting only 0.5–3 % of all intracranial meningiomas [1].
Moreover, it is extremely rare to see a metastasis of
meningioma cells (malignant meningioma), via cere-
brospinal fluid (CSF) dissemination, involved in the
diverse central nervous system (CNS) structures, such
as cerebellum, multiple cranial nerves, spinal nerve
roots and the cauda equina [2–4]. Recently, we en-
countered a patient who developed acute progressive
decline of brainstem function caused by the CSF dis-
semination of intraventricular malignant meningioma.
Here, we present the clinical and pathological data of
the patient.
Case presentation
An 81-year-old man was admitted to our hospital
following the appearance of diplopia and facial nerve palsy
on the right side. He had noted a mild unsteadiness of gait
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for 3 months, which he assumed was due to advancing
age. There were no extraordinary findings in his medical
and familial history. The patient was in good physical con-
dition and without lymphadenopathy. On neurological
examination, he had double vision, despite no obvious
limitation of extraocular muscles, peripheral facial nerve
palsy on the right side, slurred speech, and truncal ataxia.
He had no weakness or ataxia of extremities, and his
sensation was intact. He had a difficulty in micturition. He
had no headache, papilloedema, and consciousness
disturbance indicating hydrocephalus. Brain magnetic
resonance imaging (MRI) showed expansion of the fourth
ventricle and a mass lesion in the trigone of the left lateral
ventricle, which was enhanced but with some distortion
(Fig. 1a–c). This mass had been noted by chance over
6 months prior to admission when he had medical check-
up of the brain and had not changed in size. Laboratory
studies revealed that the patients’ blood cell counts and
chemistry were almost normal. Soluble interleukin 2-
receptor (sIL2-R), angiotensin-converting enzyme (ACE),
antinuclear antibody, anti-neutrophil cytoplasmic anti-
body (ANCA), and tumor markers were all within
normal limits. In addition, no anti-ganglioside anti-
bodies or anti-aquaporin-4 (AQP-4) antibodies were
present. CSF examination revealed an elevated protein
concentration (125.5 mg/dl) and cell count (white
blood cell 20 cells/μl; monocyte count, 16 cells/μl)
with normal pressure (80 mmH2O), but cytology was
negative. Because the patient initially developed per-
ipheral facial nerve palsy and a mild unsteadiness of
Fig. 1 Brain MRI of the present patient at admission (a –c), and 17 days (d–f) and 40 days (g–i) after admission. Fluid attenuated inversion recovery
(FLAIR) images at admission showed no gross abnormality, including in the brainstem and cranial nerves (a, b), although a mass-enhancing lesion was
observed in the trigone of the left lateral ventricle on T1-weighted imaging (c). 17 days after admission, FLAIR images revealed slight hyperintensity
in the exit for the trigeminal nerve and the left cerebellar hemisphere (d, e), and diffusion-weighted imaging (DWI) showed hyperintensity in the left
cerebellar hemisphere (f). At the final MRI at 40 days after admission, diffuse high-intensity lesions and hydrocephalus were observed in the brainstem
and cerebellum on FLAIR (g, h) and DWI revealed multiple hyperintense lesions in the bilateral cerebellar hemispheres (i)
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gait, and neuroimaging and laboratory findings were
nonspecific or unremarkable, we suspected that he
might have an immune-mediated disease such as
brainstem encephalitis. Thus, we initiated immuno-
logical treatments; these included intravenous methyl-
prednisolone (1000 mg/day, 3 days) and intravenous
immunoglobulins (IVIg, 0.4 g/kg, 5 days). Despite
these treatments, the brainstem symptoms progres-
sively worsened; 1 week after admission the patient
developed persistent hiccups and hyperventilation,
followed by lethargy. Fluid attenuated inversion recov-
ery (FLAIR) at 17 days after admission revealed a
Fig. 2 a: Macroscopic photograph of the intraventricular tumor. The main part of the tumor was encapsulated and solid (white arrow). The bottom
part of the tumor became prominent and soft (black arrow). b-i: Histopathology of the main part shown with a white arrow in Fig. 2a. This region
consisted of spindle-shaped fibrous cells, including a large amount of collagen deposits (b, hematoxylin & eosin (HE) stain). Using immunochemistry,
the cells positively stained for vimentin (c), epithelial membrane antigen (EMA) (d) and S-100 protein (e), but were negative for cytokeratin (f), Schwann
2/E (g), GFAP (h), Olig2 (i) and lymphocytic markers (data not shown). These cellular profiles confirmed the histological diagnosis of the tumor as
fibrous meningioma (WHO grade I). j-r: Histopathology of the part shown with a black arrow in Fig. 2a. This region showed increased cellularity, and
cells were large, atypically shaped with multiple nuclei and prominent nucleoli (j). Mitotic cells were confirmed by examining more than
20 percent high-power fields on HE (j) and Ki67 stain (k). The cells with a malignant appearance were also positive for vimentin (l), EMA
(m), S-100 protein (n) and cytokeratin (o), but negative for Schwann 2/E (p), GFAP (q) and Olig2 (r); This part of the tumor was diagnosed as anaplastic
meningioma (WHO grade III)
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slightly hyperintense lesion in the exit of the left tri-
geminal nerve and the left cerebellar hemisphere
(Fig. 1d, e). Diffusion-weighted image (DWI) of brain
MRI revealed a hyperintense lesion in the left cerebellar
hemisphere (Fig. 1f). MRI of the cervical and lumbar
spinal cord did not reveal any abnormalities (not
shown). Although oral administration of predoniso-
lone (60 mg/day) was continued, the patient’s level of
consciousness progressively deteriorated with ataxic
respiration and enhanced startle reflex. Simultaneously,
his deep tendon reflexes were lost. CSF examination was
performed repeatedly, showing mild pleocytosis (white
blood cell count 52 cells/μl; monocyte count 51 cells/μl),
but the cytology results were negative. FLAIR MRI of the
brain, at 40 days after admission, revealed slightly diffuse
hyperintense lesions in the left cerebellum and pons
with an expansion of the inferior horn of the lateral
ventricles (Fig. 1g, h). However, no obvious mass
lesions in the cerebral parenchyma or enlargement of
the tumor mass in the trigone of the left ventricle
was demonstrated. DWI showed multiple infarctions
in the left cerebellar hemisphere, pons, occipital lobe,
and bilateral corona radiata (Fig. 1i). Fifty-three days
after admission, the patient died of respiratory failure,
and an autopsy was performed.
At post-mortem the major organs showed no patho-
logical changes. In the brain, the tumor in the lateral
ventricle was solid and well-demarcated, but the sur-
face of the tumor partly collapsed (Fig. 2a). Histo-
pathological analysis of the intraventricular tumor
revealed aggregations of spindle cells including rich
collagen deposition and psammoma bodies in the
central lesion (Fig. 2b). Additionally, dense cells with a
malignant appearance (high nuclear/cytoplasmic ratio,
prominent nucleoli, and multinuclear) and increased
frequent mitoses were observed at the marginal part of
the tumor. The mitotic index was more than 20 mitoses
per ten high-power fields on hematoxylin & eosin (HE)
and Ki-67 immunostaining (Fig. 2j, k). The cells in both
benign and malignant parts were positive for vimentin
and epithelial membrane antigen (EMA), partially
positive for S-100, but negative for cytokeratin,
Schwann/2E, glial fibrillary acidic protein (GFAP) and
Olig2, suggesting that the tumor cells originated from
a meningioma (Fig. 2c-i, l-r). Thus, the pathological
diagnosis of the intraventricular tumor was a mix of
fibrous meningioma (WHO grade I) and anaplastic
meningioma (WHO grade III).
The malignant cells disseminated and invaded the par-
enchyma and small vessels of the brain – preferentially
Fig. 3 a-i: Histopathology of dissemination and infiltration of tumor cells. Copious cells invaded the surface, parenchyma and vessels of the brainstem
(a, b; medulla oblongata, c; pontine base, d; pons and trigeminal nerve), spinal cord (e; dorsal part of T2) and nerve root (f; dorsal root of L2, g; cauda
equina). The cells invaded directly from the surface and damaged the tissue structures (a, d, f). Moreover, vascular infiltration of the cells caused
ischemic necrosis around the vessels (c). The cells, which invaded the brainstem, pontine, spinal cord and nerve root, also showed the anaplastic
meningioma with a highly increased mitotic ratio (b) and were positive for vimentin (h) and EMA (i)
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invading the surface regions of the midbrain, pons and
medulla oblongata. Invasion of small vessels resulted in
ischemic damage around them. These ischemic changes,
including the brain malacia, were found in the cerebellar
white matter, pons and lower part of cerebral parenchyma
(Fig. 3a, c). Cranial nerves, such as the facial nerve, trigemi-
nal nerve, and oculomotor nerve, were packed with tumor
cells (Fig. 3d). Furthermore, tumor cells were diffusely
found adhered to the thoracic to lumbar spinal cord and
multiple nerve roots, as well as the cauda equina, which
were similarly filled with tumor cells (Fig. 3e-g). Because all
the observed tumor cells shared the same immunohisto-
chemical characteristics (Fig. 3h, i), it is possible that the
copious malignant cells originated from the anaplastic
meningioma in the left ventricle of the present patient and
disseminated extensively through the CSF, resulting in pro-
gressive dysfunction of brainstem and cerebellum.
We also performed molecular analysis for two regions
of the tumor, the fibrous cell part and the malignant cell
part. Our chromosome analysis revealed more than 500
differences of gene expressions between two regions.
Interestingly, only in the tumor from the malignant
region, the deletion of chromosome 9p21 was detected
where the genes CDKN2A and CDKN2B were located
(Fig. 4). It has been well known that the homozygous
deletions of CDKN2A/B are found in most anaplastic
meninigomas and these genes have been studied for
abnormalities in advanced meningioma [5]. Then, we
considered that the malignant region was an anaplastic
meningioma transformed from the benign cells, also in
molecular aspect. Tumor samples were collected from
the autopsy of this patient. Written informed parental
consents were obtained prior to sample collection. The
study was approved by the institutional review boards of
Juntendo University. Genome DNA was extracted
from Paraffin tissue blocks using GeneRead DNA FFPE
Kit (Cat. No.180134,QIAGEN, Hilden, Germany). The
DNA was amplified by REPLI-g FFPE Kit (Cat.
No.150243), and was investigated for genomic alteration
using the Genome-Wide Human CytoScan HD Array
(Affymetrix, CA, USA) according to the manufacture’s
protocol. Scanned data was analyzed with Chromosome
Analysis Suire v2.1 ((Affymetrix, CA, USA). SNP oligo-
nucleotide microarray analysis was perfoemed using
Affymetrix GnenChip Human Mapping 6.0 SNP array.
Sample preparation, hybridization, and scanning were
performed according to manufacture’s specifications
(Affymetrix, CA, USA). Analyses were performed using
the Genotyping Console v2.0 (Affymetrix) and Ingenuity
Pathway Analysisv7.5 (Ingenuity Systems, CA, USA).
Fig. 4 The chromosome analysis for the two tumor parts. The deletion of chromosome 9p21 was detected in the malignant region, the left side sample
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Discussion
Generally, neoplastic meningitis is not uncommon with
solid carcinoma, e.g., breast cancer, lung cancer, and
gastrointestinal cancer [6]; however, it is extremely rare
to see the CSF dissemination of intraventricular malignant
meningioma. To our knowledge, only eight such cases
have been hitherto reported [7]. In these cases, tumor
mass of meningioma in the brain or spinal cord was found
transformed from low-grade meningioma to malignant
meningioma, eventually resulting in the CSF dissemin-
ation of malignant tumor cells. In the present patient, the
solitary tumor in the lateral ventricle contained mixed
pathology of benign and malignant parts originated from
the common cellular profile of the meningioma. Of
note, unlike the previously reported cases, neuroimaging
studies could not demonstrate any tumor mass suggestive
of metastasis in the present patient. This may be one
reason for the delay in the clinical diagnosis despite
such widespread dissemination of tumor cells. CSF
dissemination of malignant tumor cells may poten-
tially cause a wide variety of neurological symptoms,
such as hydrocephalus, cerebellar dysfunction, distur-
bances of multiple spinal nerve roots or the cauda
equina, and cranial nerve palsy [4]. Conversely, brain-
stem dysfunction by CSF dissemination of malignant
cells is rare; only a few reports are available in the
literature in which Wallenberg syndrome or central
hyperventilation was induced by CSF dissemination of
malignant tumor cells [8, 9]. In the present patient,
although marked and progressive decline of brainstem
function was observed, an accurate diagnosis could
not be made until the post-mortem examination, sug-
gesting that it is by no means easy to make a prompt
diagnosis of this type of clinical condition.
Clinically, peripheral facial nerve palsy, diplopia and
unsteadiness of gait were the initial manifestations in
the present patient. These symptoms, if they occur
acutely, risk misleading the differential diagnoses
towards more frequent clinical conditions, such as
brainstem encephalitis or Fisher syndrome [10].
Unfortunately, CSF cytology, which was performed
repeatedly, did not identify any malignant cells in the
present patient. Although the specificity of CSF
cytology is high, the sensitivity is low, between 45
and 95 % [11]. Reportedly, in cases of leptomeningeal
metastasis, malignant cells were identified in the CSF
in 54 % of cases on initial lumber puncture, and
remained negative in 8 %, even after repeated examin-
ation [12]. The reason for the low specificity of the
CSF cytology in leptomeningeal metastasis remains
unclear regardless of extensive seeding of the malignant
cells via the CSF. We speculate that the malignant cells
may have a propensity to adhere easily to the meninges
rather than floating freely in the CSF.
The pathology showed that the malignant part of this
tumor was positive for cytokeratin. Cytokeratin, a known
marker of metastatic carcinoma, was expressed only in
cells of the malignant part. This finding did not rule out
the diagnosis of meningioma because cytokeratin
expression was also detected in 75 % of malignant
meningiomas [13].
Conclusion
Although it is certainly not easy to make a precise
diagnosis of this type of clinical condition, it is clinically
important to note that when seeing a patient with an
intraventricular tumor in whom any neurological symp-
toms appeared progressively, the possibility should be
kept in mind that CSF dissemination of tumor cells,
after malignant transformation, might be the potential
cause, even if CSF cytology is negative.
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